HomePHIO • NASDAQ
Follow
Phio Pharmaceuticals Corp
Previous close
$0.73
Day range
$0.66 - $0.73
Year range
$0.50 - $12.27
Market cap
1.65M USD
Avg Volume
529.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 968.00K | -8.94% |
Net income | -2.78M | 22.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.76M | 22.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.41M | -41.96% |
Total assets | 9.54M | -39.59% |
Total liabilities | 2.33M | 2.74% |
Total equity | 7.21M | — |
Shares outstanding | 2.44M | — |
Price to book | 0.23 | — |
Return on assets | -63.57% | — |
Return on capital | -80.27% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -2.78M | 22.26% |
Cash from operations | -2.90M | 17.75% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -2.90M | 17.99% |
Free cash flow | -1.82M | 15.55% |
About
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Founded
2011
Headquarters
Website
Employees
10